Neotherix is pleased to announce that we have been granted further funding from the Technology Strategy Board (TSB) in the form of a Smart Proof of Market award. Awarded to high-growth-potential SMEs, the funding will support a nine month project on "Personalised tissue repair scaffolds: assessment of market and clinical attractiveness". This will focus on understanding the clinical needs that may be met by, and the commercial potential of, the next generation of products based on our bioresorbable scaffold technology. The most attractive options developed during the study, which started this October, will form the basis for a further proposal to progress the new technology and establish proof of concept.
For more information, please see the Technology Strategy Board's Smart scheme web page .